
ELAHERE® (mirvetuximab soravtansine-gynx) for Injection, a …
ELAHERE is a prescription medicine used to treat adults with folate receptor-alpha (FRɑ) positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who: have not responded to or are no longer responding to treatment with platinum-based chemotherapy and
About ELAHERE | ELAHERE® (mirvetuximab soravtansine-gynx) for …
ELAHERE is a prescription medicine used to treat adults with folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who: have not responded to or are no longer responding to treatment with platinum-based chemotherapy and
Results With ELAHERE | ELAHERE® (mirvetuximab soravtansine …
See the results from the study, including how people responded to treatment with ELAHERE and common side effects. Please see Full Prescribing Information, including Boxed WARNING and Medication Guide.
How to care for your eyes with ELAHERE | ELAHERE® …
See what you can do to care for your eyes during treatment with ELAHERE and find an eye doctor near you. Please see Full Prescribing Information, including Boxed WARNING and Medication Guide.
ELAHERE is the firsttargeted therapy developed and approved for FRα+ platinum-resistant ovarian cancer • ELAHERE is a type of treatment called an antibody-drug conjugate (ADC)
Support | ELAHERE® (mirvetuximab soravtansine-gynx) for Injection
ELAHERE Support Services (ESS) is here to help you navigate your treatment journey with ELAHERE. Once enrolled, ESS can help you with insurance coverage questions and provide nursing support for your ELAHERE questions. Nurse Navigators offered through ELAHERE Support Services
EYE DROP TRACKER Mark each circle with an X once the drops are applied. For Days 9-21, administer your lubricating eye drops as needed. Steroid drops Infusion cycle #: Date Day before infusion Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8
- [PDF]
for More - ELAHERE
ELAHERE is a prescription medicine used to treat adults with folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who: • have not responded to or are no longer responding to treatment with platinum-based chemotherapy and
elahere是第一种针对frα+耐铂卵巢癌而开发并获得批准的靶向治疗药物 • elahere 是一种称为抗体药物偶联物(adc)的治疗药物 • 与传统化疗不同,adc 旨在以靶向方式治疗癌症 重要安全信息(续) • 有肝脏问题。 • 已怀孕或计划怀孕。elahere 可能会伤害腹中的 ...
ELAHERE
ELAHERE